JP2005312365A - リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント - Google Patents
リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント Download PDFInfo
- Publication number
- JP2005312365A JP2005312365A JP2004134683A JP2004134683A JP2005312365A JP 2005312365 A JP2005312365 A JP 2005312365A JP 2004134683 A JP2004134683 A JP 2004134683A JP 2004134683 A JP2004134683 A JP 2004134683A JP 2005312365 A JP2005312365 A JP 2005312365A
- Authority
- JP
- Japan
- Prior art keywords
- lysine
- food
- feed
- protein
- supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 239000004472 Lysine Substances 0.000 title claims abstract description 62
- 235000013305 food Nutrition 0.000 title claims abstract description 32
- 230000003579 anti-obesity Effects 0.000 title claims abstract description 16
- 239000013589 supplement Substances 0.000 title claims abstract description 14
- 230000002402 anti-lipaemic effect Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 44
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 44
- 230000037396 body weight Effects 0.000 claims abstract description 26
- 230000001315 anti-hyperlipaemic effect Effects 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 abstract description 17
- 235000012054 meals Nutrition 0.000 abstract description 14
- 208000008589 Obesity Diseases 0.000 abstract description 9
- 235000020824 obesity Nutrition 0.000 abstract description 9
- 210000000577 adipose tissue Anatomy 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 230000009467 reduction Effects 0.000 abstract description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229960003646 lysine Drugs 0.000 description 46
- 235000018977 lysine Nutrition 0.000 description 46
- 235000018102 proteins Nutrition 0.000 description 39
- 235000005911 diet Nutrition 0.000 description 23
- 230000037213 diet Effects 0.000 description 22
- 150000002632 lipids Chemical class 0.000 description 15
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 150000001720 carbohydrates Chemical class 0.000 description 13
- 238000011887 Necropsy Methods 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical group Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229960005337 lysine hydrochloride Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 235000009200 high fat diet Nutrition 0.000 description 5
- 150000003839 salts Chemical group 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical group NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 102000015781 Dietary Proteins Human genes 0.000 description 2
- 108010010256 Dietary Proteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical group CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000008085 high protein diet Nutrition 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- CPYVQXAASIFAMD-KNIFDHDWSA-N (2s)-2-aminobutanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical group OC(=O)[C@@H](N)CC(O)=O.NCCCC[C@H](N)C(O)=O CPYVQXAASIFAMD-KNIFDHDWSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229960005357 lysine acetate Drugs 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】1日の食事がタンパク質エネルギー比率が20%以下であるものの摂食の状態下で、1日当り体重1kg当り遊離態換算で40〜160mgの割合で摂取されるべきリジンを含有することを特徴とするリジン含有抗肥満または抗高脂血食品、飼料またはサプリメント、および乾物換算で0.8〜3.0重量%のリジン(遊離態換算)を含有し、かつタンパク質エネルギー比率が20%以下であることを特徴とするリジン含有抗肥満または抗高脂血食品、飼料またはサプリメント。
【選択図】図4
Description
山本辰芳監修「アミノ酸ダイエット」ゴマブックス出版2002年 三條健昌監修「アミノ酸ダイエット」日東書院出版2002年 三條健昌監修「アミノ酸で体の調子がどんどんよくなる!」三笠書房2001年
30頭からなる5週齢のC57BL/6J雄性マウスに高脂肪食(食事組成はエネルギー比として、タンパク質:脂質:炭水化物=17:46:37)を16週間供与した。16週目より、各群10頭(各群n=10)からなるマウスに、(1)20%タンパク食(LF;タンパク質:脂質:炭水化物=2:7:1)、(2)1%リジン塩酸塩添加20%タンパク食(LF1K;食事あたり1%リジン塩酸塩(リジンベースとして0.8%含有)、(3)3%リジン塩酸塩添加20%タンパク食(LF3K;食事あたり3%リジン塩酸塩(リジンベースとして2.4%含有)を8週間供与した。ここに、リジンベースは遊離態リジンを言う。また、非肥満群として、(4)試験開始時より終了時まで、すなわち24週間、20%タンパク食(タンパク質:脂質:炭水化物=2:7:1)を供与した同種のマウス10頭からなる群(LL)を設けた。飼料組成は表1に示した。
各群10頭(各群n=10)からなる9週齢のC57BL/6J雄性マウス8群に、それぞれ、(1)10%タンパク食(LP;食事組成はエネルギー比として、タンパク質:脂質:炭水化物=1:1:8)、(2)リジン添加10%タンパク食(LPK)、(3)20%タンパク食(LF;タンパク質:脂質:炭水化物=2:1:7)、(4)リジン添加20%タンパク食(LFK)、(5)40%タンパク食(MP;タンパク質:脂質:炭水化物=4:1:5)、(6)リジン添加40%タンパク食(MPK)、(7)60%タンパク食(HP;タンパク質:脂質:炭水化物=6:1:3)、および(8)リジン添加60%タンパク食(HPK)を4週間供与した。リジン添加群は食事あたり3%量のリジン塩酸塩を添加した。飼料組成は表2に示した。
各群10頭(各群n=10)からなる9週齢のC57BL/6J雄性マウス4群に、それぞれ、(1)20%タンパク食(LF;食事組成はエネルギー比として、タンパク質:脂質:炭水化物=2:7:1)、(2)高脂肪食(HF;タンパク質:脂質:炭水化物=17:46:37)、(3)1%リジン塩酸塩添加高脂肪食(HF1K;食事あたり1%リジン塩酸塩(リジンベースとして0.8%)含有)、そして(4)3%リジン塩酸塩添加高脂肪食(HF3K;食事あたり3%リジン塩酸塩リジンベースとして2.4%)含有)を8週間供与した。飼料組成は表3に示した。
Claims (5)
- 1日の食事がタンパク質エネルギー比率が20%以下である摂食の状態下で、1日当り体重1kg当り遊離態換算で40〜160mgの割合で摂取されるべきリジンを含有することを特徴とするリジン含有抗肥満または抗高脂血食品またはサプリメント。
- 乾物換算で0.8〜3.0重量%のリジン(遊離態換算)を含有し、かつタンパク質エネルギー比率が20%以下であることを特徴とするリジン含有抗肥満または抗高脂血食品またはサプリメント。
- 1日に摂取する回数が何回でも1日のリジンの摂取量が体重1kg当り40〜160mgの割合で摂取されるべきことを特徴とするリジン含有抗肥満または抗高脂血食品またはサプリメント。
- 乾物換算で0.8〜3.0重量%のリジン(遊離態換算)を含有し、かつタンパク質エネルギー比率が20%以下であることを特徴とするリジン含有抗肥満または抗高脂血飼料またはサプリメント。
- 該リジンが遊離態のリジンまたはペプチド態のリジンであることを特徴とする請求項1〜4のいずれかに記載のリジン含有抗肥満または抗高脂血食品、飼料またはサプリメント。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134683A JP4534579B2 (ja) | 2004-04-28 | 2004-04-28 | リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント |
US11/115,136 US8394401B2 (en) | 2004-04-28 | 2005-04-27 | Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine |
EP05252612A EP1593312B1 (en) | 2004-04-28 | 2005-04-27 | Use of an antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine |
DE602005009067T DE602005009067D1 (de) | 2004-04-28 | 2005-04-27 | Verwendung eines Nahrungsmittels oder Nahrungsergänzungsmittels gegen Adiposität und erhöten Blutlipiden, dass Lysin enthält |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134683A JP4534579B2 (ja) | 2004-04-28 | 2004-04-28 | リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010037889A Division JP4911374B2 (ja) | 2010-02-04 | 2010-02-04 | リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005312365A true JP2005312365A (ja) | 2005-11-10 |
JP2005312365A5 JP2005312365A5 (ja) | 2007-03-01 |
JP4534579B2 JP4534579B2 (ja) | 2010-09-01 |
Family
ID=34941050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004134683A Expired - Fee Related JP4534579B2 (ja) | 2004-04-28 | 2004-04-28 | リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント |
Country Status (4)
Country | Link |
---|---|
US (1) | US8394401B2 (ja) |
EP (1) | EP1593312B1 (ja) |
JP (1) | JP4534579B2 (ja) |
DE (1) | DE602005009067D1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009523174A (ja) * | 2006-01-10 | 2009-06-18 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 脂肪の減少を促進するための組成物及び方法 |
JP2010166917A (ja) * | 2010-02-04 | 2010-08-05 | Ajinomoto Co Inc | リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9808027B2 (en) | 2005-05-20 | 2017-11-07 | Colgate-Palmolive Company | Methods for promoting health or wellness in adult animals |
WO2008024904A1 (en) * | 2006-08-23 | 2008-02-28 | Kellogg Company | Method for suppression of fishy aromas in food products by proteins |
US9192593B2 (en) * | 2006-08-30 | 2015-11-24 | Ajinomoto Co., Inc. | Amino-acid containing composition for inhibiting accumulation of fat |
US20100331999A1 (en) * | 2009-06-29 | 2010-12-30 | Aronne Louis J | Combination Therapies for the Treatment of Obesity |
DE102018133657A1 (de) | 2018-12-28 | 2020-07-02 | Beckhoff Automation Gmbh | Basismodul und funktionsmodul für ein schaltschranksystem und schaltschranksystem |
DE102018133646A1 (de) | 2018-12-28 | 2020-07-02 | Beckhoff Automation Gmbh | Basismodul und Funktionsmodul für ein Schaltschranksystem |
DE102018133647A1 (de) | 2018-12-28 | 2020-07-02 | Beckhoff Automation Gmbh | Schaltschranksystem aus Basismodul und Funktionsmodulen sowie Funktionsmodul |
DE102019106082B4 (de) | 2019-03-11 | 2021-06-24 | Beckhoff Automation Gmbh | Schaltschranksystem mit dichtungseinsatz |
WO2023183767A1 (en) * | 2022-03-21 | 2023-09-28 | Abbott Laboratories | Methods and compositions for increasing insulin sensitivity |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61215323A (ja) * | 1985-03-20 | 1986-09-25 | Otsuka Pharmaceut Co Ltd | 栄養補給飲食品 |
JPH08140628A (ja) * | 1994-11-28 | 1996-06-04 | Meiji Milk Prod Co Ltd | ゲル化食品組成物 |
JPH09157163A (ja) * | 1995-12-06 | 1997-06-17 | Sasaki Kagaku Kogyo Kk | アミノ酸組成剤およびその摂食方法 |
JP2002511392A (ja) * | 1998-04-15 | 2002-04-16 | ニュートリスーティカル・テクノロジー・コーポレイション | 食欲と代謝を調節する方法 |
WO2002087562A1 (en) * | 2001-04-26 | 2002-11-07 | Novartis Nutrition Ag | Use of protein and essential amino acids to treat amenorrhea and related disorders |
JP2003119133A (ja) * | 2001-10-15 | 2003-04-23 | Beverly Corporation:Kk | 入浴前摂取用痩身剤 |
JP2004321171A (ja) * | 2003-04-11 | 2004-11-18 | Fancl Corp | 飲食品 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0198445A (ja) | 1987-10-12 | 1989-04-17 | Kanebo Ltd | 経口摂食組成物 |
US4937234A (en) * | 1988-08-10 | 1990-06-26 | Fahim Mostafa S | Minerals in bioavailable form |
JPH0624977A (ja) | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 抗肥満剤及び抗高脂血症剤 |
JPH08140626A (ja) | 1994-11-18 | 1996-06-04 | Power Shifuto:Kk | インスタント薬膳材料 |
WO1997043912A1 (fr) * | 1996-05-23 | 1997-11-27 | Otsuka Pharmaceutical Co., Ltd. | Composition alimentaire destinee a abaisser la teneur en graisses dans le corps et a ameliorer la composition du corps et procede afferent |
IL149907A0 (en) * | 1999-12-16 | 2002-11-10 | Mark Nutritionals Inc | Nutritional composition, methods of producing said composition and methods of using said composition |
US6475530B1 (en) * | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
EP1443946A2 (en) * | 2001-07-03 | 2004-08-11 | Nutri Pharma ASA | Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
-
2004
- 2004-04-28 JP JP2004134683A patent/JP4534579B2/ja not_active Expired - Fee Related
-
2005
- 2005-04-27 EP EP05252612A patent/EP1593312B1/en not_active Expired - Fee Related
- 2005-04-27 DE DE602005009067T patent/DE602005009067D1/de active Active
- 2005-04-27 US US11/115,136 patent/US8394401B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61215323A (ja) * | 1985-03-20 | 1986-09-25 | Otsuka Pharmaceut Co Ltd | 栄養補給飲食品 |
JPH08140628A (ja) * | 1994-11-28 | 1996-06-04 | Meiji Milk Prod Co Ltd | ゲル化食品組成物 |
JPH09157163A (ja) * | 1995-12-06 | 1997-06-17 | Sasaki Kagaku Kogyo Kk | アミノ酸組成剤およびその摂食方法 |
JP2002511392A (ja) * | 1998-04-15 | 2002-04-16 | ニュートリスーティカル・テクノロジー・コーポレイション | 食欲と代謝を調節する方法 |
WO2002087562A1 (en) * | 2001-04-26 | 2002-11-07 | Novartis Nutrition Ag | Use of protein and essential amino acids to treat amenorrhea and related disorders |
JP2003119133A (ja) * | 2001-10-15 | 2003-04-23 | Beverly Corporation:Kk | 入浴前摂取用痩身剤 |
JP2004321171A (ja) * | 2003-04-11 | 2004-11-18 | Fancl Corp | 飲食品 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009523174A (ja) * | 2006-01-10 | 2009-06-18 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 脂肪の減少を促進するための組成物及び方法 |
JP2013047251A (ja) * | 2006-01-10 | 2013-03-07 | Hill's Pet Nutrition Inc | 脂肪の減少を促進するための組成物及び方法 |
US8557869B2 (en) | 2006-01-10 | 2013-10-15 | Hill's Pet Nutrition, Inc. | Compositions and methods for promoting fat loss |
JP2010166917A (ja) * | 2010-02-04 | 2010-08-05 | Ajinomoto Co Inc | リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント |
Also Published As
Publication number | Publication date |
---|---|
US20050249781A1 (en) | 2005-11-10 |
JP4534579B2 (ja) | 2010-09-01 |
EP1593312A1 (en) | 2005-11-09 |
EP1593312B1 (en) | 2008-08-20 |
US8394401B2 (en) | 2013-03-12 |
DE602005009067D1 (de) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1593312B1 (en) | Use of an antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine | |
Yadav et al. | Impacts of dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) level and ratio on the growth, fatty acids composition and hepatic-antioxidant status of largemouth bass (Micropterus salmoides) | |
JP2002519005A (ja) | 太り過ぎのイヌにおいて体重減少を促進するための方法、及び、産物 | |
EP3019024B1 (en) | Compositions and methods for enhancing exercise performance | |
JP2011157329A (ja) | ミトコンドリア機能向上剤 | |
JP2009234924A (ja) | 免疫回復剤及びそれを含有する飼料組成物 | |
WO2012120378A1 (en) | Compositions and methods for nutritional supplementation | |
Ilsley et al. | Plant extracts as supplements for lactating sows: effects on piglet performance, sow food intake and diet digestibility | |
Adam et al. | Effect of dietary bile acids: Growth performance, immune response, genes expression of fatty acid metabolism, intestinal, and liver morphology of striped catfish (Pangasianodon hypophthalmus) | |
EP1378236B1 (en) | Agents against stress-induced diseases | |
JP6538043B2 (ja) | 腎機能を向上させるための方法及び組成物 | |
JP4911374B2 (ja) | リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント | |
WO2005112660A1 (ja) | 飼料及びγ-アミノ酪酸の供与方法 | |
JP2005080533A (ja) | 生活習慣病予防改善効果を有するタンパク質食品素材 | |
JP2021078397A (ja) | 脂質減少促進剤 | |
JP2005255574A (ja) | IgA産生恒常化剤及びそれを含有するストレス性疾患予防用及び/又は治療用組成物 | |
JP6671367B2 (ja) | 環状ジペプチド含有抗肥満用組成物 | |
Taciak et al. | The effects of feeding diets containing potato protein concentrate on reproductive performance of rats and quality of the offspring | |
Miao et al. | Effect on amino acid and mineral content of the loach (Misgurnus anguillicaudatus) by adding Fe (II) chelating hairtail protein hydrolysates (Fe (II)‐HPH) to the feed | |
JP2007117014A (ja) | 関節リウマチ症予防のための栄養補助食品 | |
EP4062764A1 (en) | Pet food | |
JP2005200390A (ja) | 持久力増強剤および抗疲労剤 | |
JP2003159007A (ja) | 牛の肉質を改善する方法 | |
Wu et al. | Effect of replacement of SDPP with yeast extracts in piglets on plasma amino acids and intestinal mucosa morphology. | |
JP2005040059A (ja) | ペットフード |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070112 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080229 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080428 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080512 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090805 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091005 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091006 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091106 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100310 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100405 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100525 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100607 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4534579 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |